Hims & Hers Health, Inc. (HIMS) stock analysis
HIMS · Hims & Hers Health, Inc.
Latest recorded price: USD 18.56
Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic
A reliable intrinsic value could not be calculated for HIMS; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 64.5%, free cash flow margin 3.2%, ROIC 7.0%. The model flags 1 risk signal for this company.
Similar companies in Healthcare
- Harrow, Inc. (HROW)
- Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA)
- Lantheus Holdings, Inc. (LNTH)
- Liquidia Corporation (LQDA)
- Neurocrine Biosciences, Inc. - Common Stock (NBIX)
- Phibro Animal Health Corporation (PAHC)
- Prestige Consumer Healthcare Inc. (PBH)
- Pacira BioSciences, Inc. (PCRX)